These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 14021857)

  • 1. [The activation of fibrinolysis by means of acid polysaccharides. II. Therapeutic prospects of a new pentosan polysulfoester].
    COCCHERI S; LORETI A; GENNARI P
    Clin Ter; 1963 Apr; 25():103-18. PubMed ID: 14021857
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study on the effect of a pentosan polysulfoester on blood coagulation and fibrinolysis].
    Henk W; Nebosis G
    Wien Klin Wochenschr; 1968 Mar; 80(10):191-4. PubMed ID: 5650711
    [No Abstract]   [Full Text] [Related]  

  • 3. [The activation of fibrinolysis by means of acid polysaccharides. I. Biological aspects].
    COCCHERI S; GENNARI P; LORETI A
    Clin Ter; 1963 Apr; 25():3-46. PubMed ID: 14021856
    [No Abstract]   [Full Text] [Related]  

  • 4. [CHANGES IN FIBRINOLYSIS CAUSED BY PROLONGED INTRAVENOUS AND RECTAL ADMINISTRATION OF AN ACID POLYSACCHARIDE].
    GIBELLI A; DELUTTEROTTI A; FRANDOLI G
    G Gerontol; 1963 Dec; 11():1319-24. PubMed ID: 14123778
    [No Abstract]   [Full Text] [Related]  

  • 5. Clot structure modification by fondaparinux and consequence on fibrinolysis: a new mechanism of antithrombotic activity.
    Varin R; Mirshahi S; Mirshahi P; Kierzek G; Sebaoun D; Mishal Z; Vannier JP; Yvonne Borg J; Simoneau G; Soria C; Soria J
    Thromb Haemost; 2007 Jan; 97(1):27-31. PubMed ID: 17200767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved coagulation in bleeding disorders by Non-Anticoagulant Sulfated Polysaccharides (NASP).
    Liu T; Scallan CD; Broze GJ; Patarroyo-White S; Pierce GF; Johnson KW
    Thromb Haemost; 2006 Jan; 95(1):68-76. PubMed ID: 16543964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human fibrinolysis: a study of bacterial lipopolysaccharide induced and spontaneous fibrinolysis.
    COCHRAN B; WHITNEY EB; WARE AG
    Pharm Acta Helv; 1958; 33(8-10):719-25. PubMed ID: 13601120
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative and temporal differences in coagulation, fibrinolysis and platelet activation after on-pump and off-pump coronary artery bypass surgery.
    Vallely MP; Bannon PG; Bayfield MS; Hughes CF; Kritharides L
    Heart Lung Circ; 2009 Apr; 18(2):123-30. PubMed ID: 19081297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1-inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis.
    Pannell R; Kung W; Gurewich V
    J Thromb Haemost; 2007 May; 5(5):1047-54. PubMed ID: 17459007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The TAFI system. The new role of fibrinolysis].
    Dempfle CE
    Hamostaseologie; 2007 Sep; 27(4):278-81. PubMed ID: 17938767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-translational modifications of human thrombin-activatable fibrinolysis inhibitor (TAFI): evidence for a large shift in the isoelectric point and reduced solubility upon activation.
    Valnickova Z; Christensen T; Skottrup P; Thøgersen IB; Højrup P; Enghild JJ
    Biochemistry; 2006 Feb; 45(5):1525-35. PubMed ID: 16445295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?
    Bouma BN; Mosnier LO
    Ann Med; 2006; 38(6):378-88. PubMed ID: 17008302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multiparameter test of clot formation and fibrinolysis for in-vitro drug screening.
    Kostka B; Para J; Sikora J
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):611-8. PubMed ID: 17890947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ruminal fermentation of pentosan.
    HOWARD BH
    Biochem J; 1955 Mar; 60(Annual General Meeting):i. PubMed ID: 14363204
    [No Abstract]   [Full Text] [Related]  

  • 15. Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIII.
    Nielsen VG; Steenwyk BL; Gurley WQ
    J Heart Lung Transplant; 2006 Oct; 25(10):1247-52. PubMed ID: 17045938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis.
    Mosnier LO; Bouma BN
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2445-53. PubMed ID: 16960106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
    Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
    FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring activation sites on polysaccharides by GC-MS.
    Kim JS; Laskowich ER; Michon F; Kaiser RE; Arumugham RG
    Anal Biochem; 2006 Nov; 358(1):136-42. PubMed ID: 16979576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfated polysaccharides inhibit the catabolism and loss of both large and small proteoglycans in explant cultures of tendon.
    Samiric T; Ilic MZ; Handley CJ
    FEBS J; 2006 Aug; 273(15):3479-88. PubMed ID: 16817908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble thrombomodulin partially corrects the premature lysis defect in FVIII-deficient plasma by stimulating the activation of thrombin activatable fibrinolysis inhibitor.
    Foley JH; Nesheim ME
    J Thromb Haemost; 2009 Mar; 7(3):453-9. PubMed ID: 19087221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.